Pacer BioThreat Strategy ETF (VIRS)
Pacer BioThreat Strategy ETF operates in the Asset Management industry of the Financial Services sector, headquartered in Malvern, PA, US. The stock last traded at $40.02, up 0.03% on the session, giving a market capitalisation of $4.0M. Its beta of 0.92 implies it has historically moved less than the broad market.
This exchange-traded fund focuses its investments on U.S.-listed companies that offer products or services aimed at protecting against, enduring, or recovering from biological threats to human health. Its portfolio manager strives to allocate nearly all of the fund's capital to the specific securities that comprise its benchmark index. Notably, this fund operates on a non-diversified basis.
Pacer BioThreat Strategy ETF is most often compared with the following Financial Services names: